Are Korean Biopharma Alliances Recovering After Gloomy Year?

Trend Toward Higher Upfronts

 
• By Jung Won Shin
alliance
Bright Prospects Seen For Korean ADC, Bispecific Antibody Deals • Source: Shutterstock

More from South Korea

More from Focus On Asia